Since B7.1 has high affinity to CTLA-4, soluble B7.1-Fc may block CTLA-4 signaling instead of cross-linking CTLA-4, thereby sustaining the activation of tumor-specific T cells [18,19]. This evidence concerns the gene CTLA4 and neoplasm.